デフォルト表紙
市場調査レポート
商品コード
1375505

輸血デバイス市場:製品別、エンドユーザー別-2023-2030年の世界予測

Blood Transfusion Devices Market by Product (Apheresis Device, Blood Bag, Blood Component Separator), End-user (Ambulatory Surgical Centres, Blood Bank, Hospital) - Global Forecast 2023-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 188 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
輸血デバイス市場:製品別、エンドユーザー別-2023-2030年の世界予測
出版日: 2023年10月16日
発行: 360iResearch
ページ情報: 英文 188 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

輸血デバイス市場は、2022年の38億6,000万米ドルから2030年には67億米ドルに達すると予測され、予測期間中のCAGRは7.11%です。

輸血デバイスの世界市場

主な市場の統計
市場金額:基準年[2022] 38億6,000万米ドル
推定市場金額[2023] 41億2,000万米ドル
予測市場金額[2030] 67億米ドル
CAGR(%) 7.11%
輸血デバイス Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは輸血デバイス市場の評価に不可欠なツールです。事業戦略や製品満足度に関連する主要指標を分析し、ベンダーを包括的に評価します。これにより、ユーザーは特定のニーズに合わせた情報に基づいた意思決定を行うことができます。高度な分析により、ベンダーは4つの象限に分類され、それぞれ成功のレベルが異なります:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。この洞察に満ちたフレームワークにより、意思決定者は自信を持って市場をナビゲートすることができます。

市場シェア分析

市場シェア分析では、ベンダーの市場情勢に関する貴重な洞察を提供します。全体収益、顧客ベース、その他の主要指標への影響を評価することで、企業の業績と直面する競合環境を包括的に理解することができます。この分析では、調査期間中の市場シェア獲得、断片化、優位性、業界再編などの競合レベルも明らかにします。

本レポートは、以下の側面に関する貴重な洞察を提供しています:

1.市場の浸透度:主要企業の市場力学と製品に関する包括的な情報を提供します。

2.市場の開拓度:新興市場と成熟市場セグメントへの浸透度を詳細に分析し、有利なビジネスチャンスを浮き彫りにします。

3.市場の多様化:新製品の発売、未開拓の地域、最近の開発、投資に関する詳細情報。

4.競合の評価と情報:主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価。

5.製品開発およびイノベーション:将来の技術、研究開発活動、画期的な製品開発に関するインテリジェントな洞察。

本レポートは、以下のような主要な質問に対応しています:

1.輸血デバイス市場の市場規模および予測は?

2.輸血デバイス市場で最も高い投資ポテンシャルを持つ製品、セグメント、用途、分野は?

3.輸血デバイス市場における競争戦略の窓とは?

4.輸血デバイス市場の最新技術動向と規制の枠組みは?

5.輸血デバイス市場における主要ベンダーの市場シェアは?

6.輸血デバイス市場への参入に適した形態や戦略的手段は?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 血液関連疾患とがんの罹患率

世界的に

      • 政府の支援とスクリーニング済み血液製剤の需要による啓発キャンペーンの拡大
      • 世界中で交通事故の増加と手術件数の増加
    • 抑制要因
      • 輸血デバイスの制作コストが高い
    • 機会
      • 技術的に進んだスクリーニング分析装置の利用可能性が急増
      • 輸血デバイスの機能を改善するための継続的な調査
    • 課題
      • 承認のための厳格な規制ポリシー
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 輸血デバイス市場:製品別

  • アフェレーシス装置
  • 血液バッグ
  • 血液成分分離装置
  • 血液混合器
  • 消耗品と消耗品
  • 輸液ポンプ
  • 病原体低減システム

第7章 輸血デバイス市場:エンドユーザー別

  • 外来手術センター
  • 血液バンク
  • 病院

第8章 南北アメリカの輸血デバイス市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域の輸血デバイス市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカの輸血デバイス市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析:主要企業別
  • 競合シナリオ分析:主要企業別

第12章 競争力のあるポートフォリオ

  • 主要企業プロファイル
    • Abbott Laboratories
    • B. Braun SE
    • Baxter International Inc.
    • Becton Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • bioMerieux SA
    • Ecomed Solutions
    • EryPharm
    • F.Hoffman-La Roche AG
    • Fresenius Kabi Malaysia Sdn. Bhd.
    • Fresenius SE & Co. KGaA
    • Grifols, S.A.
    • Haemonetics Corporation
    • Jiangsu Kangjin Medical Instrument Co.,Ltd.
    • Kawasumi Laboratories, Inc.
    • Macopharma
    • Nipro Medical Corporation
    • Ortho-Clinical Diagnostics, Inc.
    • Quotient Suisse SA
    • Sarstedt AG & Co. KG
    • Siemens AG
    • SURU INTERNATIONAL PVT. LTD.
    • Terumo Corporation
  • 主要な製品ポートフォリオ

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. BLOOD TRANSFUSION DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. BLOOD TRANSFUSION DEVICES MARKET SIZE, 2022 VS 2030
  • FIGURE 3. BLOOD TRANSFUSION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. BLOOD TRANSFUSION DEVICES MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. BLOOD TRANSFUSION DEVICES MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. BLOOD TRANSFUSION DEVICES MARKET DYNAMICS
  • FIGURE 7. BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 8. BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 10. BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 12. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 14. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. BLOOD TRANSFUSION DEVICES MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 20. BLOOD TRANSFUSION DEVICES MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. BLOOD TRANSFUSION DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. BLOOD TRANSFUSION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS DEVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BAG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COMPONENT SEPARATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD MIXER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CONSUMABLES & SUPPLIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. BLOOD TRANSFUSION DEVICES MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PATHOGEN REDUCTION SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 14. BLOOD TRANSFUSION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BANK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. BLOOD TRANSFUSION DEVICES MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 104. BLOOD TRANSFUSION DEVICES MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 105. BLOOD TRANSFUSION DEVICES MARKET LICENSE & PRICING
目次
Product Code: MRR-521BAA36EB0A

The Blood Transfusion Devices Market is projected to reach USD 6.70 billion by 2030 from USD 3.86 billion in 2022, at a CAGR of 7.11% during the forecast period.

Global Blood Transfusion Devices Market

KEY MARKET STATISTICS
Base Year Value [2022] USD 3.86 billion
Estimated Year Value [2023] USD 4.12 billion
Forecast Year Value [2030] USD 6.70 billion
CAGR (%) 7.11%
Blood Transfusion Devices Market - IMG1

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Blood Transfusion Devices Market.

Based on Product, market is studied across Apheresis Device, Blood Bag, Blood Component Separator, Blood Mixer, Consumables & Supplies, Infusion Pumps, and Pathogen Reduction System. The Pathogen Reduction System is projected to witness significant market share during forecast period.

Based on End-user, market is studied across Ambulatory Surgical Centres, Blood Bank, and Hospital. The Ambulatory Surgical Centres is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Blood Transfusion Devices Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Blood Transfusion Devices Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Blood Transfusion Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, B. Braun SE, Baxter International Inc., Becton Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Ecomed Solutions, EryPharm, F.Hoffman-La Roche AG, Fresenius Kabi Malaysia Sdn. Bhd., Fresenius SE & Co. KGaA, Grifols, S.A., Haemonetics Corporation, Jiangsu Kangjin Medical Instrument Co.,Ltd., Kawasumi Laboratories, Inc., Macopharma, Nipro Medical Corporation, Ortho-Clinical Diagnostics, Inc., Quotient Suisse SA, Sarstedt AG & Co. KG, Siemens AG, SURU INTERNATIONAL PVT. LTD., and Terumo Corporation.

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Blood Transfusion Devices Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Blood Transfusion Devices Market?

3. What is the competitive strategic window for identifying opportunities in the Blood Transfusion Devices Market?

4. What are the latest technology trends and regulatory frameworks in the Blood Transfusion Devices Market?

5. What is the market share of the leading vendors in the Blood Transfusion Devices Market?

6. Which modes and strategic moves are suitable for entering the Blood Transfusion Devices Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Blood Transfusion Devices Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of blood-related disorders and cancer

globally

      • 5.1.1.2. Growing awareness campaigns with government support and demand for screened blood products
      • 5.1.1.3. Rising cases of road accidents and increase in number of surgeries worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of production of blood transfusion devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Surge in availability of technologically advanced screening analyzers
      • 5.1.3.2. Ongoing research to improve the functionality of blood transfusion devices
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulatory policies for approval
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Blood Transfusion Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Apheresis Device
  • 6.3. Blood Bag
  • 6.4. Blood Component Separator
  • 6.5. Blood Mixer
  • 6.6. Consumables & Supplies
  • 6.7. Infusion Pumps
  • 6.8. Pathogen Reduction System

7. Blood Transfusion Devices Market, by End-user

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centres
  • 7.3. Blood Bank
  • 7.4. Hospital

8. Americas Blood Transfusion Devices Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Blood Transfusion Devices Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Blood Transfusion Devices Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. Abbott Laboratories
    • 12.1.2. B. Braun SE
    • 12.1.3. Baxter International Inc.
    • 12.1.4. Becton Dickinson and Company
    • 12.1.5. Bio-Rad Laboratories, Inc.
    • 12.1.6. bioMerieux SA
    • 12.1.7. Ecomed Solutions
    • 12.1.8. EryPharm
    • 12.1.9. F.Hoffman-La Roche AG
    • 12.1.10. Fresenius Kabi Malaysia Sdn. Bhd.
    • 12.1.11. Fresenius SE & Co. KGaA
    • 12.1.12. Grifols, S.A.
    • 12.1.13. Haemonetics Corporation
    • 12.1.14. Jiangsu Kangjin Medical Instrument Co.,Ltd.
    • 12.1.15. Kawasumi Laboratories, Inc.
    • 12.1.16. Macopharma
    • 12.1.17. Nipro Medical Corporation
    • 12.1.18. Ortho-Clinical Diagnostics, Inc.
    • 12.1.19. Quotient Suisse SA
    • 12.1.20. Sarstedt AG & Co. KG
    • 12.1.21. Siemens AG
    • 12.1.22. SURU INTERNATIONAL PVT. LTD.
    • 12.1.23. Terumo Corporation
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing